Anti-neutrophil cytoplasmic antibody
Anti-Neutrophil Cytoplasmic Antibody (ANCA)[edit]


Anti-neutrophil cytoplasmic antibodies (ANCA) are specific types of antibodies directed against certain proteins found within neutrophils, the most common type of white blood cell. Their presence is strongly associated with certain forms of autoimmune vasculitis, where the body's immune system mistakenly attacks its blood vessels.
Overview[edit]
ANCAs have become increasingly recognized for their role in the pathogenesis and diagnosis of a subset of vasculitides known as ANCA-associated vasculitides (AAV). These conditions lead to inflammation and damage to blood vessels, primarily affecting small-sized vessels.
Pathogenesis[edit]
Neutrophils, which play a crucial role in the body's defense against infections, contain various proteins. In individuals with ANCA, the immune system produces antibodies against these proteins, leading to neutrophil activation and subsequent vessel inflammation, resulting in vasculitis.
Types of ANCA[edit]
There are mainly two types of ANCAs based on their staining patterns when observed under a microscope:
- c-ANCA (cytoplasmic ANCA): Primarily targets proteinase 3 (PR3). Commonly associated with granulomatosis with polyangiitis (GPA).
- p-ANCA (perinuclear ANCA): Targets myeloperoxidase (MPO). Often linked with microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA).
Clinical Implications[edit]
ANCA testing is instrumental in diagnosing, classifying, and monitoring disease activity in patients with suspected ANCA-associated vasculitis. While ANCAs are valuable diagnostic markers, their levels do not always correlate with disease severity.
Diseases Associated with ANCA[edit]
- Granulomatosis with polyangiitis (GPA)
- Microscopic polyangiitis (MPA)
- Eosinophilic granulomatosis with polyangiitis (EGPA)
Treatment[edit]
Management of ANCA-associated vasculitis generally involves:
- Immunosuppressive therapies to reduce inflammation and halt the immune system's abnormal response.
- Regular monitoring for disease activity and potential relapses.
- Addressing and managing complications arising from organ involvement.

Other names[edit]
ANCA antibodies, cANCA pANCA, cytoplasmic neutrophil antibodies, serum, anticytoplasmic autoantibodies
Clinical use[edit]
ANCA test is used to diagnose autoimmune vasculitis.
Types of autoimmune vasculitis[edit]
Types of autoimmune vasculitis include:
- Granulomatosis with polyangiitis (GPA), )Wegener's disease) affecting the lungs, kidneys, and sinuses.
- Microscopic polyangiitis (MPA) affecting lungs, kidneys, nervous system, and skin.
- Eosinophilic granulomatosis with polyangiitis (EGPA), (Churg-Strauss syndrome) affects skin and lungs. It often causes asthma.
- Polyarteritis nodosa (PAN) affecting the heart, kidneys, skin, and central nervous system.
Symptoms[edit]

- Fever
- Fatigue
- Weight loss
- Muscle and/or joint aches
- Eyes
- Redness
- Blurred vision
- Loss of vision
- Ears
- Ringing in the ears (tinnitus)
- Hearing loss
- Sinuses
- Sinus pain
- Runny nose
- Nose bleeds
- Skin
- Rashes
- Sores or ulcers, a type of deep sore that's slow to heal and/or keeps coming back
- Lungs
- Cough
- Trouble breathing
- Chest pain
- Kidneys
- Blood in the urine
- Foamy urine, which is caused by protein in the urine
- Nervous system
- Numbness and tingling in different parts of the body
Test results[edit]
If your ANCA is negative, it means your symptoms are probably not due to autoimmune vasculitis.
If you test positive for ANCA, it may indicate autoimmune vasculitis.
The test can also show which ANCA, either cANCAs or pANCAs were found which can help determine which type of vasculitis you have.
See Also[edit]
References[edit]
<references />
| Autoantibodies | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


